Skip to content

Bioengineer.org | Asymptomatic TB Resists Single Tests, Review Argues for Staged Pathways

2 November 2026

Bioengineer.org media review

People with TB who report no symptoms at screening represent one of the most stubborn obstacles to disease control, and a new narrative review argues that the problem cannot be solved by any single test. Writing in Frontiers in Cellular and Infection Microbiology, researchers from China and Guangxi synthesize current evidence on how asymptomatic TB is defined, detected and misclassified, and conclude that effective diagnosis will require staged, risk-stratified pathways rather than standalone screening tools.

The review’s central conceptual point is that asymptomatic TB is a symptom-defined and method-dependent phenotype, not a uniform biological stage. Individuals classified as asymptomatic may carry minimal or extensive radiographic abnormalities, shed bacilli at low or intermittent levels, or harbor clinically inapparent disease that remains stable, regresses, fluctuates or progresses. Because terminology, symptom ascertainment, population risk and diagnostic intensity vary across studies and programs, estimates of how common asymptomatic disease is differ widely and cannot be compared directly.

Read the full media review here.

 

Source: Bioengineer.org

Back To Top